Cipla Limited — Others, 01-08-2025: News Verification

Cipla has addressed a media report regarding US government letters sent to global drug manufacturers concerning drug pricing. The company clarified it has not received any such communication as mentioned in the news article and is therefore unable to comment on the matter. Cipla also stated it is not aware of any information beyond the public domain that could explain the recent trading movements in its securities. This update clarifies that the reported event does not directly involve Cipla based on their current information.